Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics.
about
Altered cardiac electrophysiology and SUDEP in a model of Dravet syndromeHuman Induced Pluripotent Stem Cell-Derived Cardiomyocytes Afford New Opportunities in Inherited Cardiovascular Disease ModelingInherited arrhythmias: The cardiac channelopathiesInduced pluripotent stem cells for cardiovascular disease: from product-focused disease modeling to process-focused disease discoveryCardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem CellsInduced pluripotent stem cell-derived cardiomyocytes for cardiovascular disease modeling and drug screeningTranslating stem cell research to cardiac disease therapies: pitfalls and prospects for improvementDisease modeling and cell based therapy with iPSC: future therapeutic option with fast and safe applicationHuman iPS cell model of type 3 long QT syndrome recapitulates drug-based phenotype correctionModelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytesModeling tissue- and mutation- specific electrophysiological effects in the long QT syndrome: role of the Purkinje fiberGenome editing of isogenic human induced pluripotent stem cells recapitulates long QT phenotype for drug testingThe disease-specific phenotype in cardiomyocytes derived from induced pluripotent stem cells of two long QT syndrome type 3 patients.Calcium transients closely reflect prolonged action potentials in iPSC models of inherited cardiac arrhythmia.Modeling Inherited Arrhythmia Disorders Using Induced Pluripotent Stem Cell-Derived Cardiomyocytes.From Bench to Market: Preparing Human Pluripotent Stem Cells Derived Cardiomyocytes for Various ApplicationsInvestigating human disease using stem cell models.iPCS Cell Modeling of Inherited Cardiac Arrhythmias.Human stem cells for modeling heart disease and for drug discovery.Genome-wide association studies and contribution to cardiovascular physiologyiPSC technology--Powerful hand for disease modeling and therapeutic screenToward Personalized Medicine: Using Cardiomyocytes Differentiated From Urine-Derived Pluripotent Stem Cells to Recapitulate Electrophysiological Characteristics of Type 2 Long QT SyndromeFinding the rhythm of sudden cardiac death: new opportunities using induced pluripotent stem cell-derived cardiomyocytesAutomated Electrophysiological and Pharmacological Evaluation of Human Pluripotent Stem Cell-Derived Cardiomyocytes.The investigation of sudden arrhythmic death syndrome (SADS)-the current approach to family screening and the future role of genomics and stem cell technology.Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform.Modeling susceptibility to drug-induced long QT with a panel of subject-specific induced pluripotent stem cells.Use of induced pluripotent stem cells to recapitulate pulmonary alveolar proteinosis pathogenesis.Induced pluripotent stem cell-derived cardiomyocytes: boutique science or valuable arrhythmia model?Cardiac sodium channelopathy associated with SCN5A mutations: electrophysiological, molecular and genetic aspects.Induced pluripotent stem cells as cardiac arrhythmic in vitro models and the impact for drug discovery.Pluripotent stem cells as a platform for cardiac arrhythmia drug screeningDeranged sodium to sudden death.Cardiac disease modeling using induced pluripotent stem cell-derived human cardiomyocytes.Cardiomyopathy in a dish: using human inducible pluripotent stem cells to model inherited cardiomyopathies.Human induced pluripotent stem cell for modeling cardiovascular diseases.Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes as a Model for Heart Development and Congenital Heart Disease.Genetics of long-QT syndrome.Generating patient-specific induced pluripotent stem cells-derived cardiomyocytes for the treatment of cardiac diseases.From iPSC towards cardiac tissue-a road under construction.
P2860
Q21089741-14880AD2-8682-42CC-A418-DE910F68646BQ26750618-DB2133E3-FEF3-47FA-95E9-6CE2D918B267Q26778079-5E736276-F4F6-4783-9716-2B26A2F9374BQ26781825-4CE46221-AA9A-4431-8414-DF2170C706F1Q26798131-1B4AECFB-2856-4500-ACFB-E0355FEF6DB4Q26828408-72FB09DA-4FBD-4DE2-AD2E-2ED1CF0F8EEFQ26860340-E077BA77-0999-4474-8FCC-59E76A39ACF2Q26866409-EB39ECC3-4917-4F19-9AD7-85D8F0294B37Q27322725-9D45B089-8C63-4EE9-B572-587CA6FCDB53Q28255887-68F50E39-D363-45F6-BF92-8A2F7D1D80C3Q28539295-370D22A5-DBD5-4378-BA5C-9644B270D534Q30586646-DE5A4270-8BE1-4C1C-9318-F9F6CE383757Q33163638-ACB6D92C-3E5E-4D6E-A887-7503A580B99DQ33164771-CB66F6F1-C01C-4A72-95DD-2C8B66C1BAC3Q33704567-94C40F48-196A-45A2-9305-2CF908005841Q33847517-FBE92139-42CA-4D6A-B4DB-EAE17E8B0C9AQ34431170-26737063-3344-460D-88C8-757CB56B868EQ34431713-B8570202-7016-4F44-AD24-8D8C20A0AB0DQ34433363-76212F47-B16B-4110-B88B-66C0096760BFQ36017794-97117425-D823-4FB9-BC29-D687D0DF747FQ36082427-56710247-6330-4E43-87AF-7676078AB201Q36141836-2BB80DFD-2D7D-4D5F-A721-732183D873F8Q36365384-3E6A8755-A031-409D-B87D-AA94EE81041BQ36683233-95931414-59F8-4632-8F95-D2A348C25F11Q37165579-62142824-D555-48AA-8BA5-7107499E22DDQ37573646-12518506-B184-4548-BDD1-0A90B80C99EFQ37613893-66378CFF-B3CA-4376-8605-0A3B08126285Q37698322-86268800-18B0-4FBA-9F35-6B22E99BC4BDQ38097414-4FABB09B-9486-4C60-8E6B-1BFBFEF2CE15Q38118751-49E15125-BBD2-44BC-8818-0612526305DDQ38167806-F999873F-3A0A-4FA7-81C9-9017A125BC4DQ38235190-476B8182-B7E9-49FE-BC13-DD069E259A1EQ38378616-8D987076-CB33-468C-928A-1CF3A43C139AQ38393181-0CD87D4D-4791-44C9-BDCF-4D8AEB021751Q38454536-286F5E28-45E4-4F59-8671-F446CF6744B8Q38487497-DC47882C-9281-4AD0-8CAA-0536E7D5BDB2Q38530607-46BE032C-AF01-4E1A-8B50-39E3788880C3Q38537058-B100227B-4283-4FE7-8D45-4F55DE99E608Q38541742-07C8A8FD-75F8-4D47-B384-59D816120406Q38675863-A89183C7-A58F-4451-9968-88493F462B52
P2860
Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Induced pluripotent stem cells ...... family with complex genetics.
@en
Induced pluripotent stem cells ...... family with complex genetics.
@nl
type
label
Induced pluripotent stem cells ...... family with complex genetics.
@en
Induced pluripotent stem cells ...... family with complex genetics.
@nl
prefLabel
Induced pluripotent stem cells ...... family with complex genetics.
@en
Induced pluripotent stem cells ...... family with complex genetics.
@nl
P2093
P2860
P50
P356
P1476
Induced pluripotent stem cells ...... family with complex genetics.
@en
P2093
Amel Omari
Cecile Terrenoire
Jonathan T Lu
Kelvin W Chan Tung
Kevin J Sampson
Robert H Pass
Robert S Kass
Wendy K Chung
P2860
P356
10.1085/JGP.201210899
P577
2013-01-01T00:00:00Z